A-19241129

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameA-19241129
Drug Alias NameA-192411A-192411.29
ClassificationSmall molecules > Heterocyclic drugs > Antifungals
Mechanisms of Action1,3-beta-glucan synthase inhibitors
Targets1,3-beta-glucan synthase
Therapy Area/IndicationsMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsMycoses

Other Information

ATC CodeN/A
Related LinksN/A